wsbdaily | Tue, 20 Dec 2022 03:11:23 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Ardelyx, Inc.(ARDX)
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis... Read More
Summary & Charts
| Price | $ 1.57 | +0.07 (+4.66%) |
| Day's Range | $ 1.51 - 1.59 | |
| Previous Close | $ 1.50 | |
| Market Cap | $ 231.95M USD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | NasdaqGM | |
| Industry | Biotechnology | |
| Sector | Healthcare | |
| Volume | 2.34M | |
| Avg. Volume (20 day) | 2.57M | |
| Rel. Volume (20 day) | 0.91 | |
| Rel. Volume (3 month) | 0.69 | |
| Rating | B+ | Neutral |
| DCF | N/A | Strong Buy |
| Debt/Equity | 148.12 % | Buy |
| ROE | -191.74 % | Strong Sell |
| ROA | -102.45 % | Sell |
| P/E | -1.69 % | Sell |
| P/B | 4.31 % | Strong Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Nov 01, 2022 | $ 1.51 | $ 1.59 | $ 1.51 | $ 1.57 | +0.07 | 2,338,142 | 0.91 | 0.69 | |
| Oct 31, 2022 | $ 1.46 | $ 1.57 | $ 1.45 | $ 1.50 | +0.05 | 3,536,802 | 1.32 | 1.06 | 2 |
| Oct 28, 2022 | $ 1.40 | $ 1.47 | $ 1.36 | $ 1.45 | +0.07 | 2,110,352 | 0.77 | 0.65 | |
| Oct 27, 2022 | $ 1.43 | $ 1.44 | $ 1.35 | $ 1.38 | -0.02 | 2,191,941 | 0.79 | 0.69 | |
| Oct 26, 2022 | $ 1.39 | $ 1.44 | $ 1.34 | $ 1.40 | +0.04 | 2,947,903 | 1.06 | 0.94 | |
| Oct 25, 2022 | $ 1.44 | $ 1.48 | $ 1.34 | $ 1.36 | -0.07 | 3,567,432 | 1.28 | 1.16 | |
| Oct 24, 2022 | $ 1.49 | $ 1.50 | $ 1.42 | $ 1.43 | -0.05 | 1,621,701 | 0.60 | 0.53 | |
| Oct 21, 2022 | $ 1.44 | $ 1.52 | $ 1.38 | $ 1.48 | +0.04 | 2,091,475 | 0.77 | 0.68 | |
| Oct 20, 2022 | $ 1.43 | $ 1.53 | $ 1.41 | $ 1.44 | +0.03 | 1,984,107 | 0.71 | 0.65 | |
| Oct 19, 2022 | $ 1.52 | $ 1.52 | $ 1.37 | $ 1.41 | -0.11 | 2,724,137 | 0.98 | 0.90 | |
| Oct 18, 2022 | $ 1.52 | $ 1.55 | $ 1.49 | $ 1.52 | +0.04 | 1,761,142 | 0.64 | 0.58 | |
| Oct 17, 2022 | $ 1.42 | $ 1.53 | $ 1.41 | $ 1.48 | +0.10 | 2,743,422 | 1.00 | 0.90 | |
| Oct 14, 2022 | $ 1.42 | $ 1.48 | $ 1.38 | $ 1.38 | -0.01 | 2,035,399 | 0.75 | 0.67 | |
| Oct 13, 2022 | $ 1.34 | $ 1.42 | $ 1.30 | $ 1.39 | +0.03 | 1,918,291 | 0.69 | 0.63 | |
| Oct 12, 2022 | $ 1.42 | $ 1.42 | $ 1.36 | $ 1.36 | -0.05 | 1,631,976 | 0.59 | 0.53 | |
| Oct 11, 2022 | $ 1.40 | $ 1.47 | $ 1.35 | $ 1.41 | 1,861,206 | 0.64 | 0.60 | ||
| Oct 10, 2022 | $ 1.53 | $ 1.53 | $ 1.38 | $ 1.41 | -0.14 | 3,259,765 | 0.95 | 1.05 | |
| Oct 07, 2022 | $ 1.59 | $ 1.60 | $ 1.50 | $ 1.55 | -0.06 | 2,371,405 | 0.69 | 0.76 | 1 |
| Oct 06, 2022 | $ 1.51 | $ 1.64 | $ 1.50 | $ 1.61 | +0.10 | 4,706,248 | 1.31 | 1.51 | 1 |
| Oct 05, 2022 | $ 1.35 | $ 1.54 | $ 1.33 | $ 1.51 | +0.14 | 4,088,846 | 1.07 | 1.32 |
News
The latest news about Ardelyx, Inc. (ARDX).
Seeking Alpha | 2022-10-24 02:13:50
Tenapanor's approved indication for IBS is enjoying early signs of market success. Ardelyx shares are running up toward the ADCOM decision for tenapanor's label expansion for hyperphosphatemia which is tentatively set for November 16.
Seeking Alpha | 2022-10-18 06:09:35
The FDA will convene an Advisory Committee on November 16 to discuss the new drug application for XPHOZAH. Background material will be available to the public two business days before the meeting.
PennyStocks | 2022-10-04 13:56:47
Penny stocks with unusual options activity to watch today. The post Penny Stocks To Buy Now: 3 To Watch With Unusual Options Activity Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks | 2022-09-13 12:47:43
Red Hot Biotech Penny Stocks To Watch Right Now The post Why The Stock Market Is Down Today & 4 Penny Stocks To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks | 2022-09-06 11:54:58
Penny stocks to buy according to top money managers. The post 4 Hot Penny Stocks To Buy Now According To Top Hedge Funds appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks | 2022-09-02 12:28:17
Are these penny stocks to buy now or avoid in September? The post Best Penny Stocks To Buy Now?
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2022-11-03 | BMO | -0.17 | -- | -- | 3.9M | -- | -- |
| 2022-08-04 | BMO | -0.19 | -0.19 | -- | -- | -- | -- |
| 2022-05-05 | BMO | -0.22 | -0.21 | 4.55% | 489K | 468K | -4.35% |
| 2022-02-28 | BMO | -0.3 | -0.31 | 3.33% | 0.9M | 1M | 18.27% |
| 2021-11-12 | BMO | -0.35 | -0.42 | 20% | 0.7M | 1.2M | 67.57% |
| 2021-08-13 | BMO | -0.36 | -0.45 | 25% | 1.3M | 1.3M | -- |
| 2021-05-06 | BMO | -0.33 | -0.34 | 3.03% | 6.4M | 6.6M | 3.12% |
| 2021-03-08 | BMO | -0.26 | -0.32 | 23.07% | -- | -- | -- |
Top Discussions
These are the top discussions over the last 24-hours that mention the ARDX stock ticker symbol.
Unusual Option Activity
Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.
| Type | Strike | Exp Date | DTE | Bid | Ask | Last | Volume | Open Interest | Vol/OI | IV |
|---|---|---|---|---|---|---|---|---|---|---|
| CALL | $ 2.00 | 11/17/22 | 15 | $ 0.30 | $ 0.35 | $ 0.34 | 2,423 | 777 | 3.12 | 3.42% |
| PUT | $ 2.50 | 04/20/23 | 169 | $ 0.75 | $ 1.70 | $ 1.50 | 20 | 10 | 2.00 | 1.24% |
| PUT | $ 5.00 | 04/20/23 | 169 | $ 3.30 | $ 3.80 | $ 3.80 | 44 | 18 | 2.44 | 1.35% |
| PUT | $ 3.00 | 01/18/24 | 442 | $ 0.35 | $ 4.50 | $ 2.47 | 20 | 12 | 1.67 | 2.00% |
Last Updated: Tue, 1 Nov 2022 22:16 EST
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Tue, 14 Dec 2021 12:00 EST
@wsbdaily
wsbdaily